ANIX — Anixa Biosciences Balance Sheet
0.000.00%
Last trade - 00:00
- $101.78m
- $77.50m
- $0.21m
- 25
- 18
- 48
- 21
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 5.84 | 9.06 | 35.7 | 29.7 | 23.8 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.067 | 0.002 | — | — | 0.27 |
Prepaid Expenses | |||||
Total Current Assets | 6.09 | 9.37 | 36 | 30.2 | 25.4 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.201 | 0.054 | 0.254 | 0.212 | 0.166 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 6.29 | 9.45 | 36.3 | 30.4 | 25.5 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 1.48 | 1.19 | 1.27 | 2.04 | 2.03 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.06 | 0.692 | 0.82 | 1.36 | 1.19 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 5.24 | 8.76 | 35.4 | 29 | 24.3 |
Total Liabilities & Shareholders' Equity | 6.29 | 9.45 | 36.3 | 30.4 | 25.5 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |